💡 Metabotropic glutamate receptors (mGluRs) play a crucial role in modulating excitatory neurotransmission in the central nervous system (CNS), making them promising drug targets for neurological and psychiatric disorders. 
 

Explore with Dr. Floriane Eshak on how to develop a highly potent and selective mGlu2 receptor agonist with structure-based drug design methods in BIOVIA Discovery Studio and molecular docking with GOLD. 

Watch the on-demand webinar to learn more about the impact of advanced molecular modeling in accelerating CNS-targeted drug discovery: http://go.3ds.com/UXGz.